Drugdiscovery >> Pharmaceutical Companies >> News
6285
Views
Merck, AstraZeneca ovarian cancer drug deal - drugdiscovery.com
Merck, AstraZeneca ovarian cancer drug deal - drugdiscovery.com


AstraZeneca will take over from Merck the clinical development of a potential ovarian cancer treatment , MK-1775, which is in mid-stage clinical testing as a possible oral treatment for certain forms of ovarian cancer when used with other therapies.
Read More >>


Tags: Merck, AstraZeneca, deal, ovarian cancer, drug, development - September 12, 2013
Related Articles
1754
Views
Bristol-Myers is going to end its drug development researches Bristol-Myers is going to end its drug development researches
Bristol-Myers Squibb announced that it will discontinue drug discovery in three disease branches. They also announced a lay-off affecting 70 to 75 researchers working on discovering drugs. Read More >>

Tags: Bristol-Myers, Squibb, BMY, Merck, MRK, AstraZeneca, AZN.LN, research, development, corporate

4062
Views
AstraZeneca links with privately held company to research cancer AstraZeneca links with privately held company to research cancer
AstraZeneca has announced that its biologic development arm is going to co-operate with Immunocore Limited. This is a privately held company and works on T-cell related researches. Read More >>

Tags: T-cell, AstraZeneca, Immunocore, co-operation

2945
Views
MMV and Merck Serono are ciollaborating on findig anti malaria drug MMV and Merck Serono are ciollaborating on findig anti malaria drug
MMC and Marck Serono set up a group which is working on a chemical series that has shown significant antimalarial potential. The series has a unique profile as the compounds are long-acting and have d Read More >>

Tags: in vitro, malaria drug, Merck, MMV, malaaria

4008
Views
AstraZeneca and Pfizer merger: Do cancer patients loose? AstraZeneca and Pfizer merger: Do cancer patients loose?
Even the most-sold drug of Pfizer was an aquisition. therefore, expert predict that the company can only survive if it merges with others. Read More >>

Tags: pfizer, astrazeneca, pfizer merge, astra zeneca aquisition

5052
Views
Sanofi - Pozen deal Sanofi - Pozen deal
The two companies agreed that Sanofi handles U.S. marketing of Pozen’s experimental cardiovascular drugs PA8140 and PA32540, intended as an alternative to aspirin as a secondary treatment for the pr Read More >>

Tags: Sanofi, Pozen, deal, agreement, US marketing, experimental cardiovascular drugs, PA8140, PA32540

3310
Views
Merck and Samsung are to develop new Diabetics Drug Merck and Samsung are to develop new Diabetics Drug
MK-1293, an insulin glargine candidate provides a good therapy for patients with diabetes type 1 and type 2. Merck and Samsung announced that they are going to collaborate over developing a more effec Read More >>

Tags: durg, diabetes, diabetes type 1, Merck, samsung

3553
Views
Cancer in France: a step forward Cancer in France: a step forward
Ovarian cancer is still one of the most dangerous dieases, since it is often misdiagnosed or could not be found by doctors at all. By the funding of a new biotechnological company in France there migh Read More >>

Tags: cancer, ovarian cancer, biotechnology

4648
Views
AbbVie’s cystic fibrosis deal AbbVie’s cystic fibrosis deal
AbbVie enters into collaboration with Dutch drug developer Galapagos NV with the aim to study treatments for cystic fibrosis. The deal could be worth more than $405 million to Galapagos. Read More >>

Tags: AbbVie, Galapagos, cystic fibrosis, deal

4039
Views
The price of AstraZeneca 's stock increased after Pfizer's offer The price of AstraZeneca 's stock increased after Pfizer's offer
The price of AstraZeneca stocks runned up after Pfizer announced that it is willing to buy o buy the company for around $100 billion. Lately, AstraZeneca turned down another similar offer. Read More >>

Tags: Stock, pharmaceutival business, pharmaceutical companies, AstraZeneca,Pfizer, pharmaceutical stock exchange, pharma stocks, astrazeneca sold

4840
Views
What is happening with AstraZeneca. What is happening with AstraZeneca.
Pfizer announced to buy AstraZeneca many times. But what is in the backround of this diecision and what is happening with the two companies? Read More >>

Tags: Astra Zeneca, Pfizer, pharmaceutical companies, astraZeneca business.

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013